US stock futures dip as Nvidia earnings spark little cheer
Investing.com - Voyager Therapeutics Inc reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Voyager Therapeutics Inc announced earnings per share of $0.450 on revenue of $41.09M. Analysts polled by Investing.com EPS of $-0.317 on revenue of $11.56M.
Voyager Therapeutics Inc 's are down 27% and is trading at $5.380 , still down 49.25% from its 52 week high of $10.60 set on Wednesday, April 20, 2022.
Voyager Therapeutics Inc shares gained 12.32% to trade at $5.380 in intra-day trade the report.
Voyager Therapeutics Inc follows other major Healthcare sector earnings this month
Voyager Therapeutics Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar